Expert Video - Why are Black American lung cancer patients less likely to participate in clinical trials?

Janine Harewood, MD, discusses Black Americans' medical distrust as a barrier to lung cancer clinical trial participation. Many Black Americans are less likely to participate in clinical trials for lung cancer due to social and economic factors that affect Black healthcare, such as low access and a lack of lung cancer treatment options and low Black American awareness of lung cancer clinical trials.

  • Share with family and friends:

Click here to take our SURVEY
Your feedback is important to us! We will use your feedback to develop future areas of content about lung cancer which will help other patients, caregivers and families.

Patient Stories: